지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.1
- 수록면
- 294 - 296 (3page)
이용수
초록· 키워드
오류제보하기
등록된 정보가 없습니다.
목차
등록된 정보가 없습니다.
참고문헌 (17)
참고문헌 신청
The Korean Association for the Study of the Liver / 2018 / KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications / Clinical and Molecular Hepatology 24(3):169~229
AASLD/IDSA HCV Guidance Panel / 2015 / Hepatitis C guidance: AASLDIDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus / Hepatology 62:932~954
European Association for the Study of the Liver / 2018 / EASL recommendations on treatment of hepatitis C 2018 / J Hepatol 69:461~511
Lawitz E / 2013 / Sofosbuvir for previously untreated chronic hepatitis C infection / N Engl J Med 369:678~679
Zeuzem S / 2014 / Sofosbuvir and ribavirin in HCV genotypes 2 and 3 / N Engl J Med 370:1993~2001
AASLD/IDSA HCV Guidance Panel / 2015 / Hepatitis C guidance: AASLDIDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus / Hepatology 62:932~954
European Association for the Study of the Liver / 2018 / EASL recommendations on treatment of hepatitis C 2018 / J Hepatol 69:461~511
Lawitz E / 2013 / Sofosbuvir for previously untreated chronic hepatitis C infection / N Engl J Med 369:678~679
Zeuzem S / 2014 / Sofosbuvir and ribavirin in HCV genotypes 2 and 3 / N Engl J Med 370:1993~2001
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
Clinical and Molecular Hepatology
2018 .01
-
Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose
Gut and Liver
2020 .01
-
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
Clinical and Molecular Hepatology
2019 .01
-
Patient acceptability and efficacy of simeprevir and sofosbuvir in hepatitis C after allogeneic stem cell transplantation
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
Clinical and Molecular Hepatology
2023 .04
-
Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
Clinical and Molecular Hepatology
2021 .01
-
Is the Prevalence of Chronic Hepatitis B Really Increasing in Korea?
Journal of Korean Medical Science
2024 .01
-
Comparison of the Clinical Characteristics and Outcomes between Leprosy-Affected Persons in Sorokdo and the General Population Affected by Chronic Hepatitis C in Korea
Gut and Liver
2019 .01
-
Genotypes of Hepatitis C Virus in Relapsed and Non-respondent Patients and their Response to Anti-Viral Therapy in District Mardan, Khyber Pakhtunkhawa, Pakistan
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Outcomes of hepatitis C virus treatment with ledipasvir/ sofosbuvir in Mongolian population: Successes and challenges facing scale-up of care
Clinical and Molecular Hepatology
2021 .01
-
Clinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study
Gut and Liver
2017 .01
-
Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced
Gut and Liver
2017 .01
-
Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon α Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection
Gut and Liver
2015 .01
-
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
Clinical and Molecular Hepatology
2018 .01
-
Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
Clinical and Molecular Hepatology
2015 .01
-
Current and future strategies for the treatment of chronic hepatitis C
Clinical and Molecular Hepatology
2021 .01
-
Chronic Hepatitis C Virus Infection, Why Not Treat Now?
대한류마티스학회지
2018 .01
-
Apolipoprotein E Genotype and Expression Correlated with Hepatitis C Virus Genotype and Infection
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2019 .03
-
Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims’ Data
Gut and Liver
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0